NATAMYCIN - Generic Drug Details

What are the generic sources for natamycin and what is the scope of patent protection?

Natamycin is the generic ingredient in one branded drug marketed by Harrow Eye and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for natamycin. One supplier is listed for this compound.

Summary for NATAMYCIN

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	35
Clinical Trials:	9
What excipients (inactive ingredients) are in NATAMYCIN?	NATAMYCIN excipients list
DailyMed Link:	NATAMYCIN at DailyMed

Recent Clinical Trials for NATAMYCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Aravind Eye Hospitals, India	PHASE3
Aravind Eye Care System	PHASE3
University of California, San Francisco	PHASE3

See all NATAMYCIN clinical trials

Pharmacology for NATAMYCIN

Drug Class

Polyene Antimicrobial

Medical Subject Heading (MeSH) Categories for NATAMYCIN

Anti-Bacterial Agents

Anti-Infective Agents, Local

Antifungal Agents

Anatomical Therapeutic Chemical (ATC) Classes for NATAMYCIN

A01AB	Antiinfectives and antiseptics for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

A07AA	Antibiotics
A07A	INTESTINAL ANTIINFECTIVES
A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A	Alimentary tract and metabolism

D01AA	Antibiotics
D01A	ANTIFUNGALS FOR TOPICAL USE
D01	ANTIFUNGALS FOR DERMATOLOGICAL USE
D	Dermatologicals

G01AA	Antibiotics
G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G	Genito-urinary system and sex hormones

S01AA	Antibiotics
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for NATAMYCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Harrow Eye	NATACYN	natamycin	SUSPENSION;OPHTHALMIC	050514-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes

NATAMYCIN Market Analysis and Financial Projection

Last updated: February 13, 2026

What Are the Market Dynamics for Natamycin?

Natamycin, an antifungal agent primarily used in ophthalmic, food, and pharmaceutical applications, is subject to evolving market factors influencing its demand and supply.

Key Drivers

• Food Industry Regulation and Trends: Natamycin is approved for use as a surface preservative in cheese, sausage, and other dairy products to inhibit mold growth. Its adoption correlates with regulatory approval statuses and consumer preferences for natural preservatives.

• Medical Applications: Used in ophthalmology to treat fungal keratitis. The prevalence of fungal eye infections and increases in cases linked to contact lens use drive demand.

• Regulatory Environment: Approval varies globally. The U.S. Food and Drug Administration (FDA) approves Natamycin (marketed as Natacyn) for ocular use. European Union approvals are similar, but some countries impose restrictions on food additive applications.

Market Challenges

• Alternative Preservatives: Rising use of other antifungal agents and preservatives, including potassium sorbate and sorbic acid, can limit Natamycin's growth.

• Regulatory Restrictions: Stringent rules in certain regions reduce its applicability in food products, affecting overall market size.

• Production Capacity Constraints: Manufacturing depends on microbial fermentation processes, which face scalability and cost issues that influence market availability and pricing.

Competitive Landscape

• Manufacturers: Major companies include Pfizer, FMC Corporation, and VWR International.

• Pricing Trends: Prices are influenced by raw material costs, regulatory hurdles, and supply chain stability.

• Research & Development: Ongoing R&D aims to expand applications, such as in newer drug delivery systems or broader food preservative roles.

What Is the Financial Trajectory of Natamycin?

Historical Revenue and Market Size

• Estimated global market size for Natamycin was valued at approximately USD 50 million in 2022. Compound annual growth rate (CAGR) is projected at 5% from 2023 to 2030, driven by increasing applications in food preservation and ophthalmology.

Revenue Breakdown

Segment	Market Share (2022)	Growth Rate (2023–2030)	Notes
Food Preservation	60%	4%	Driven by dairy product regulation and consumer trends
Ophthalmic	30%	7%	Growth due to rising fungal infections and contact lens use
Pharmaceutical	10%	3%	Limited but steady; includes drug formulations

Regional Market Distribution

Region	Share (2022)	Growth Rate (2023–2030)	Notes
North America	35%	4.5%	Mature market, demand driven by medical use
Europe	30%	4%	Tighter regulations somewhat hamper growth
Asia-Pacific	25%	6.5%	Rapid industrialization, expanding food markets
Rest of World	10%	5%	Emerging markets with increasing food safety standards

Revenue Trends and Projections

• 2022: USD 50 million
• 2025 (Projected): USD 62.5 million
• 2030 (Projected): USD 80 million

Investment and R&D Impact

Recent investments target process optimization, cost reduction, and new regulatory clearances, which could influence future revenue streams positively.

What Are the Key Considerations for Market Entry or Expansion?

• Regulatory Approvals: Confirm regional acceptance for food and medical use.
• Supply Chain Stability: Ensure microbial fermentation capacity aligns with demand.
• Partnerships: Collaborate with regional distributors or research entities to expand the application scope.
• Intellectual Property: Secure patents around new formulations or delivery methods to differentiate offerings.

Key Takeaways

• Natamycin's market is centered on food preservation and ophthalmic uses, with a niche but growing footprint.
• Market growth depends on regulatory approvals, consumer preferences for natural preservatives, and the prevalence of fungal infections.
• Revenue is expected to increase steadily, with Asia-Pacific showing the highest growth potential.
• Challenges include competition from alternative preservatives and regulatory restrictions limiting food additive applications.
• R&D investments are pivotal in expanding use cases and improving production efficiency.

FAQs

1. What are the primary applications of Natamycin?
It is mainly used as a food preservative to inhibit mold, especially in dairy products, and in ophthalmology to treat fungal eye infections.

2. How does regulation affect Natamycin's market?
Approval restrictions vary by country, impacting its use in food safety and medical markets, which in turn influence global demand.

3. What are the main competitors to Natamycin?
Alternatives include potassium sorbate, sorbic acid, and newer antifungal compounds used in food and medical applications.

4. Is the market for Natamycin expected to grow?
Yes, with a projected CAGR of approximately 5% up to 2030, driven by expanding applications and regions.

5. What are potential areas for innovation?
Developing new formulations, improving production processes, and expanding indications in food preservation and medicine.

---

Citations

[1] MarketsandMarkets, "Natamycin Market," 2022.
[2] Food and Drug Administration, "Approval Status of Natamycin," 2022.
[3] Grand View Research, "Antifungal Drugs Market," 2023.
[4] Euromonitor, "Food Preservatives Market," 2022.
[5] Pharmaceutical Technology, "Natamycin in Ophthalmology," 2021.